Onelax Senna Syrup
NDC Package 71399-0027-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Onelax Senna (senna) syrups is take preferably at bedtime or as directed by a doctor. This formulation utilizes a syrup delivery system. Marketed by Akron Pharma Inc., this product is identified by NDC 71399-0027 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
71399-0027-8
Package Description
237 mL in 1 BOTTLE
Product Code
71399-0027
11-Digit Billing Format
71399002708
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
237 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Onelax Senna
Non-Proprietary Name
Senna
Substance Name
Sennosides A And B
Dosage Form
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
SENNOSIDES A AND B 417.12 mg/237mL
Usage Information
Take preferably at bedtime or as directed by a doctor. Shake Well Before Using.

Regulatory & Marketing

Labeler Name
Akron Pharma Inc.
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-06-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71399-0027-8 identifies a specific commercial package of 237 ml in 1 bottle of Onelax Senna, a human over the counter drug labeled by Akron Pharma Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This syrup is formulated for oral use and contains sennosides a and b as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Akron Pharma Inc. on February 06, 2024. The current certification is valid through December 31, 2026.

How is this Akron Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71399002708. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71399-0027-8
11-Digit CMS (5-4-2)
71399-0027-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.